Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Gilliland

Showing results (151-160 of 182) with videos related to

Pageof 19
Sort By:
Blood|April 18, 2014
Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesisRaajit Rampal, Fatima Al-Shahrour, Omar Abdel-Wahab, et al.
Blood|June 5, 2004
Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AMLJingrui Jiang, J Guillermo Paez, Jeffrey C Lee, et al.
Nature Medicine|July 10, 2010
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemiaMichael G Kharas, Christopher J Lengner, Fatima Al-Shahrour, et al.
Cell|June 4, 2009
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cellsClaudia Scholl, Stefan Fröhling, Ian F Dunn, et al.
Blood|September 30, 2008
Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cellsEllen Weisberg, Johannes Roesel, Guido Bold, et al.
Cancer Cell|July 19, 2002
CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)Louise M Kelly, Jin-Chen Yu, Christina L Boulton, et al.
Journal of Biomolecular Screening|July 28, 2016
Development of a High-Throughput Gene Expression Screen for Modulators of RAS-MAPK Signaling in a Mutant RAS Cellular ContextBryan Severyn, Thi Nguyen, Michael D Altman, et al.
The Journal of Clinical Investigation|March 17, 2009
The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse modelThomas Mercher, Glen D Raffel, Sandra A Moore, et al.
Cell|September 3, 2011
AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemiasStephen M Sykes, Steven W Lane, Lars Bullinger, et al.
Blood|February 7, 2008
High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemiaMarc M Loriaux, Ross L Levine, Jeffrey W Tyner, et al.
Pageof 19

Showing results (151-160 of 182) with videos related to

Sort By:
Pageof 19
Blood|April 18, 2014
Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesisRaajit Rampal, Fatima Al-Shahrour, Omar Abdel-Wahab, et al.
Blood|June 5, 2004
Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AMLJingrui Jiang, J Guillermo Paez, Jeffrey C Lee, et al.
Nature Medicine|July 10, 2010
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemiaMichael G Kharas, Christopher J Lengner, Fatima Al-Shahrour, et al.
Cell|June 4, 2009
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cellsClaudia Scholl, Stefan Fröhling, Ian F Dunn, et al.
Blood|September 30, 2008
Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cellsEllen Weisberg, Johannes Roesel, Guido Bold, et al.
Cancer Cell|July 19, 2002
CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)Louise M Kelly, Jin-Chen Yu, Christina L Boulton, et al.
Journal of Biomolecular Screening|July 28, 2016
Development of a High-Throughput Gene Expression Screen for Modulators of RAS-MAPK Signaling in a Mutant RAS Cellular ContextBryan Severyn, Thi Nguyen, Michael D Altman, et al.
The Journal of Clinical Investigation|March 17, 2009
The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse modelThomas Mercher, Glen D Raffel, Sandra A Moore, et al.
Cell|September 3, 2011
AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemiasStephen M Sykes, Steven W Lane, Lars Bullinger, et al.
Blood|February 7, 2008
High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemiaMarc M Loriaux, Ross L Levine, Jeffrey W Tyner, et al.
Pageof 19